495 oral FIVE-YEAR SURVIVAL IN A RANDOMIZED PHASE III TRIAL OF CONCURRENT RADIOCHEMOTHERAPY WITH 5-DAY VERSUS WEEKLY CISPLATIN IN LOCALLY ADVANCED CERVICAL CANCER